Susan E. Graf's most recent trade in Cg Oncology Inc. was a trade of 15,600 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 4, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cg Oncology Inc. | Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
Finch Therapeutics Group Inc | Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 44,843 | 44,843 | - | - | Stock Option (right to buy) | |
Finch Therapeutics Group Inc | Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2021 | 23,419 | 23,419 | - | - | Stock Option (right to buy) |